蛋白质激酶C三角酶介导在ACTH分泌的垂体瘤细胞系中Pasireotide作用
E Gentilin1,2, P Borges De Souza3, M R Ambrosio3
1Bioacoustics Research Laboratory, Department of Neurosciences, University of Padua, Padua, Italy. erica.gentilin@unipd.it.
Journal of endocrinological investigation
|May 26, 2023
概括
蛋白激酶C三角酶 (PRKCD) 可能预测在库辛氏病中对帕西里奥提德治疗的反应. 过度表达PRKCD增强了帕西雷胺对ACTH分泌的垂体瘤细胞的影响.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 皮质otroph瘤是具有挑战性的管理由于持久性和复发后手术.
- 帕西雷奥提德是批准用于治疗库辛病的治疗方法,当手术不可行时.
- 帕西雷奥提德的疗效有所不同,因此需要生物标志物来确定治疗反应.
研究的目的:
- 为了研究蛋白质激酶C三角酶 (PRKCD) 在调解帕西雷的作用中的作用.
- 探索PRKCD作为一种潜在的响应标志物用于帕西里欧提德治疗.
主要方法:
- 在具有改变PRKCD水平的AtT20/D16v-F2细胞中评估细胞活力,POMC表达和ACTH分泌.
- 研究了PRKCD沉默和过度表达对帕西里欧提德治疗反应的影响.
主要成果:
- 帕西雷奥提德显著降低了细胞活力,POMC表达和ACTH分泌.
- 帕西雷奥提德治疗降低了miR-26a的表达.
- 沉默PRKCD降低了对帕西里欧提德的敏感性,而过度表达增强了其抑制作用.
结论:
- PRKCD在帕西雷奥提德的作用机制中起作用.
- 在ACTH分泌下垂体瘤中,PRKCD可以作为治疗反应的预测生物标志物.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
GPCRs Regulate Adenylyl Cylase Activity
5.7K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.7K


